<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04019483</url>
  </required_header>
  <id_info>
    <org_study_id>NL62233.041.17</org_study_id>
    <nct_id>NCT04019483</nct_id>
  </id_info>
  <brief_title>Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke</brief_title>
  <acronym>ENCLOSE</acronym>
  <official_title>Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Netherlands Organisation for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Over 20.000 people suffer an ischemic stroke in the Netherlands each year. Large&#xD;
      artery occlusions are easy to identify and can be treated with endovascular clot removal. 70%&#xD;
      of patient will however suffer from a more distal occlusion resulting in small volume stroke&#xD;
      or a transient ischemic attack (TIA). Small ischemic lesions are hard to detect with current&#xD;
      acute stroke protocols. TIA and small volume stroke patients, are at an increased risk for&#xD;
      recurrent stroke, making immediate diagnosis critical. Because thrombo-embolic sources often&#xD;
      cause these strokes, identifying and treating the underlying aetiology has the potential to&#xD;
      radically lower the risk of recurrence and improve the outcome of these patients.&#xD;
&#xD;
      Objectives: 1) To identify clinical and imaging predictors of recurrent stroke; 2) To improve&#xD;
      early detection of small volume stroke with admission computed tomography perfusion (CTP) in&#xD;
      patients with suspected acute ischemic stroke with small volume stroke or no ischemia on&#xD;
      admission imaging.&#xD;
&#xD;
      Study design: Prospective, multicenter cohort study.&#xD;
&#xD;
      Study population: All patients who visited the University Medical Center (UMC) Utrecht, the&#xD;
      Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center (AMC)&#xD;
      or the St. Antonius Hospital and who underwent a CT-scan of the brain within 9 hours after&#xD;
      onset of stroke symptoms with an age ≥18 years. Within 36 months, 720 patients will be&#xD;
      enrolled in the study. Of these patients, 300 patients will be included for the follow-up&#xD;
      magnetic resonance imaging (MRI).&#xD;
&#xD;
      Main study parameters/endpoints: The main study endpoints are: 1) Stroke recurrence rate at 2&#xD;
      years; 2) Presence and volume of acute ischemic lesions on follow-up diffusion weighted&#xD;
      imaging MRI.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2018</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent ischemic stroke</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrent ischemic stroke</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin scale</measure>
    <time_frame>90 days</time_frame>
    <description>The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6 with &quot;0&quot; being perfect health without symptoms to &quot;6&quot; being death.&#xD;
0 - No symptoms.&#xD;
- No significant disability. Able to carry out all usual activities, despite some symptoms.&#xD;
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.&#xD;
- Moderate disability. Requires some help, but able to walk unassisted.&#xD;
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.&#xD;
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.&#xD;
- Dead.&#xD;
9 - No data.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18 years or older with acute stroke symptoms who visited the UMC Utrecht, the&#xD;
        Amsterdam UMC, location AMC or the St. Antonius Hospital and who underwent a CT-scan within&#xD;
        9 hours after onset of stroke symptoms.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18 years;&#xD;
&#xD;
          -  Time from symptom onset until imaging is &lt;9 hours*;&#xD;
&#xD;
          -  Clinical diagnosis of acute ischemic stroke or TIA;&#xD;
&#xD;
          -  Informed consent from patient or family after the admission scan (unless the patient&#xD;
             died).&#xD;
&#xD;
               -  Patients who awaken with stroke symptoms can only be included if they went to&#xD;
                  sleep without any stroke symptoms and the time from going to sleep until imaging&#xD;
                  is less than 9 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with another diagnosis such as intracerebral hemorrhage, subarachnoid&#xD;
             hemorrhage or tumor;&#xD;
&#xD;
          -  Patients with known contrast allergy or renal failure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frans Kauw, MD</last_name>
    <phone>+3188-7571680</phone>
    <email>f.kauw-3@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valeria Guglielmi, MD</last_name>
      <phone>+3120-5664591</phone>
      <email>v.guglielmi@amsterdamumc.nl</email>
    </contact>
    <investigator>
      <last_name>Charles B.L.M. Majoie, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valeria Guglielmi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan M. Coutinho, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wouter van Es, MD PhD</last_name>
      <phone>+3188-3208064</phone>
      <email>h.es@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Wouter van Es, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frans Kauw, MD</last_name>
      <phone>+31 88 75 716 80</phone>
      <email>f.kauw-3@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Jan W Dankbaar, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frans Kauw, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard A.P. Takx, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 10, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2019</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>Jan. W. Dankbaar, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Recurrence</keyword>
  <keyword>Infarct detection</keyword>
  <keyword>CT</keyword>
  <keyword>MRI</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

